Adolore Biotherapeutics, Inc. | WebDisclosure

Basculer en Français

10165	Companies
208904	Keywords
138973	Articles
110712	Press releases

Headlines Articles Press releases Adolore Biotherapeutics, Inc.

Home
Companies
Adolore Biotherapeutics, Inc.

PRESS RELEASE

published on 05/16/2024 at 16:00, 1 year 10 months ago

Adolore BioTherapeutics Announces Publication Demonstrating Carbonic Anhydrase-8 Gene Therapy (rdHSV-CA8) Decreased Pain-Sensing Neuronal Excitability by Activating Kv7 Voltage-Gated Potassium Channels
Adolore BioTherapeutics announces groundbreaking findings in gene therapy for chronic pain treatment, highlighting the value of non-opioid analgesics and progress with IND-enabling studies

Adolore BioTherapeutics Chronic Pain Gene Therapy Non-opioid Analgesics IND-enabling Studies
BRIEF

published on 03/04/2024 at 16:05, 2 years 1 month ago

Adolore BioTherapeutics obtient un brevet américain pour la thérapie génique CA8* dans le traitement de la douleur chronique

Adolore BioTherapeutics Thérapie Génique Traitement De La Douleur Chronique Solutions Sans Opioïdes Délivrance De Brevet
BRIEF

published on 03/04/2024 at 16:05, 2 years 1 month ago

Adolore BioTherapeutics Secures U.S. Patent for CA8* Gene Therapy in Chronic Pain Treatment

Adolore BioTherapeutics Gene Therapy Chronic Pain Treatment Opioid-Free Solutions Patent Issuance
PRESS RELEASE

published on 03/04/2024 at 16:00, 2 years 1 month ago

Adolore BioTherapeutics Announces Issuance of First U.S. Patent Covering CA8* Gene Therapies to Treat Chronic Pain
Adolore BioTherapeutics licenses patent and CA8* gene therapy technology from the University of Miami for opioid-free chronic pain treatment. Company progresses toward clinical testing and commercialization

University Of Miami Adolore BioTherapeutics Chronic Pain Opioid-free Gene Therapy
PRESS RELEASE

published on 01/30/2024 at 16:00, 2 years 2 months ago

Adolore BioTherapeutics to Present at the 5th Annual National Institutes of Health (NIH) HEAL Initiative Scientific Meeting
Adolore BioTherapeutics will present at the 5th Annual NIH HEAL Initiative Scientific Meeting regarding the gene therapy program for chronic pain associated with knee osteoarthritis. The program is supported by NIH/NINDS HEAL UH3 Award

Adolore BioTherapeutics Chronic Pain NIH HEAL Initiative Gene Therapy Osteoarthritis
PRESS RELEASE

published on 12/05/2023 at 16:30, 2 years 4 months ago

Adolore BioTherapeutics Presents Promising Preclinical Data Supporting Its Innovative Gene Therapy to Treat Chronic Pain
Adolore BioTherapeutics presented preclinical data supporting its innovative CA8* gene therapy as a long-acting local analgesic for chronic osteoarthritis knee pain management, aiming to replace opioids

Adolore BioTherapeutics CA8* Gene Therapy Chronic Pain Opioid-free Preclinical Data
PRESS RELEASE

published on 10/11/2023 at 16:00, 2 years 5 months ago

Adolore BioTherapeutics to Participate at the Virtual Investor Ask the CEO Conference
PRESS RELEASE

published on 10/03/2023 at 15:15, 2 years 6 months ago

NIN/NINDS HEAL Program Grants Prestigious UH3 Award to the University of Miami, Principal Investigator Roy C. Levitt M.D, to Fund Clinical Development of Adolore BioTherapeutics’ Gene Therapy Program for the Treatment of Chronic Osteoarthritis Knee Pain

Accesswire

Published on 04/07/2026 at 09:30, 1 hour 6 minutes ago

Formation Metals to Host Live Investor Webinar on the N2 Gold Project to Discuss Phase 1 Drill Results, including 1.75 g/t Au over 30.4 Metres, and Maiden Resource Estimate Following Fully Funded 30,000-Metre Program
Published on 04/07/2026 at 09:05, 1 hour 31 minutes ago

BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries
Published on 04/07/2026 at 09:01, 1 hour 35 minutes ago

Apex Drills 81.6 m of 2.02% REO, including 50.9 m of 2.40% REO, Extending Strike Length of Main Body, with Highly Enriched NdPr Zone at Rift
Published on 04/07/2026 at 08:00, 2 hours 36 minutes ago

Caledonia Mining Corporation Plc: Encouraging Results From Deep Level Drilling at Blanket Mine
Published on 04/07/2026 at 00:02, 10 hours 34 minutes ago

Evergold Announces Closing of $5.4 Million Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 04/07/2026 at 10:05, 31 minutes ago

Ye celebrates his birthday on June 8 with a show at GelreDome; free bus transport arranged for fans from Germany
Published on 04/07/2026 at 10:00, 36 minutes ago

Les dix ans de Swiss Prime Fondation de placement – un exercice 2025 couronné de succès
Published on 04/07/2026 at 09:13, 1 hour 23 minutes ago

Apprenticeship 2026: Entry-level salaries reflect economic change
Published on 04/07/2026 at 09:11, 1 hour 25 minutes ago

Huge land holdings, promising drill results: An exciting new gold story is unfolding in Liberia
Published on 04/07/2026 at 09:08, 1 hour 28 minutes ago

Holding(s) in Company

Les Echos

Published on 04/07/2026 at 08:30, 2 hours 6 minutes ago

Edenred achieves CDP “A” rating and joins the ranks of global leaders in climate action
Published on 04/07/2026 at 08:30, 2 hours 6 minutes ago

Edenred obtient la note « A » au CDP et rejoint les leaders mondiaux engagés pour le climat
Published on 04/07/2026 at 08:00, 2 hours 36 minutes ago

Global Agreement Announced at G7 One Health Summit to Accelerate Access to Diagnostics and Responses to Rising Health Threats
Published on 04/07/2026 at 08:00, 2 hours 36 minutes ago

Un pacte mondial annoncé lors du G7 One Health Summit pour accélérer l'accès aux diagnostics face aux menaces sanitaires croissantes
Published on 04/06/2026 at 15:00, 19 hours 36 minutes ago

FinanceWire Introduces Certidox to Enable Verifiable Press Releases as Fake Content Becomes Indistinguishable from Reality

View all LES ECHOS COMFI WIRE